on 8 Feb 2023
TM5 Status
LIVE/REGISTRATION/Issued and Active
Your registration has been issued and is active. You can now use the TM5 mark.
Last Applicant/ Owned by
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
55218 Ingelheim
DE
Serial Number
2087122 filed on 1st Dec 2020
Registration Number
TMA1164904 registered on 8th Feb 2023
Registration expiry Date
1st Dec 2030Correspondent Address
MARKS & CLERK
33 Yonge Street, Suite 300Toronto
ONTARIO
CA
M5E1G4
Trademark usage description
pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of central nervous system disea Read More11
2087122
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 3rd Jun 2022 | Search Recorded |
Submitted for opposition 20 on 3rd Jun 2022 | Examiner's First Report |
Submitted for opposition 257 on 10th Feb 2022 | Designation Notification - Madrid Protocol |
Submitted for opposition 256 on 27th Dec 2021 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 25th Feb 2021 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 24th Feb 2021 | Formalized |
Submitted for opposition 1 on 24th Feb 2021 | Created |
Submitted for opposition 210 on 1st Dec 2020 | IR Correction |
Submitted for opposition 228 on 1st Dec 2020 | International Registration |
Submitted for opposition 30 on 1st Dec 2020 | Filed |
This website uses cookies
Manage cookies
You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.
Advertisement
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously
Analytics
Analytical cookies are used to understand how visitors interact with the website.
Functional
Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website.